In this episode, Suzanne Spradley and Chase Cannon discuss a September 2025 presidential announcement regarding tariffs on pharmaceutical products. Suzanne provides some background on the announcement and what it might mean for the U.S. and other countries. Suzanne and Chase explore the potential benefits and drawbacks of a new website relating to prescription drugs. Suzanne closes the podcast by outlining the potential impact on employer-sponsored group health plans and drug plans.